Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers May 8, 2020
Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX™ Product Development and Commercialization April 28, 2020
DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program April 27, 2020
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit April 20, 2020 Life Science
Avalon GloboCare Achieves Major Milestones Advancing Immunotherapeutic Program towards Combatting Cytokine Storm Associated with COVID-19 Lung Damage and Mortality April 20, 2020 Life Science
Healthcare Roundup – Gilead up 6% after hours on remdesivir buzz in COVID-19, New York, East Coast states extend lockdown to May 15 April 16, 2020 Life Science
Ovation Provides Corporate Update and Plans for Continued Growth Due to Coronavirus (Covid-19) April 7, 2020 Life Science
WELL Health Reports 2019 Annual Audited Results; Revenues More Than Triple March 31, 2020 Life Science
WELL Health Announces Automated Phone, SMS and Web-based COVID-19 Triage Tool for Canadians March 27, 2020 Life Science
WELL Health Announces $5.94M Strategic Investment in Insig Corporation, a Leader in Telehealth Services to support Canadian Doctors and Patients March 26, 2020 Life Science
DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the “US White House – Call to Action” to Analyse and Transform COVID-19 Data into Clinical Knowledge March 25, 2020 Life Science
WELL Health to Host 2019 Annual and Fourth Quarter Investor Conference Call March 24, 2020 Life Science
